Shabnum Patel

发表

The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Ezequiel Bernabeu, Gustavo Helguera, T. Daniels, 2012, Biochimica et biophysica acta.

CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma.

K. Davis, Y. Natkunam, M. Ozawa, 2020, Blood.

Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report

K. Davis, B. Sahaf, C. Mackall, 2020, Journal for ImmunoTherapy of Cancer.

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

K. Davis, Y. Natkunam, M. Ozawa, 2021, Nature Medicine.

Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy.

C. Bollard, Shabnum Patel, R. Burga, 2016, Nanomedicine.

A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies

A. Perelson, D. Irvine, B. Walker, 2020, The Journal of experimental medicine.

Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)

K. Davis, K. Kong, D. Miklos, 2019, Blood.

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

R. Tibshirani, S. Plevritis, Snehit Prabhu, 2022, Nature Medicine.

Functionally Active HIV-specific T cells that Target gag and nef can be expanded from Virus-naive Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT

C. Cruz, S. Lam, C. Bollard, 2016 .

A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae

C. Rooney, C. Bollard, D. Kontoyiannis, 2018, Molecular therapy. Methods & clinical development.

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Mariella G. Filbin, Shawn M. Gillespie, K. Davis, 2022, Nature.

Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

P. Hanley, E. Chorvinsky, C. Cruz, 2019, Front. Oncol..

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

R. Siliciano, B. Walker, D. Nixon, 2018, The Journal of clinical investigation.

HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths.

C. Cruz, E. Shpall, C. Bollard, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo.

C. Kovacs, C. Bollard, R. B. Jones, 2020, The Journal of clinical investigation.

BCL-2 Antagonism Sensitizes CTL-Resistant HIV Reservoirs to Elimination Ex Vivo

C. Bollard, R. B. Jones, W. Hardy, 2019, SSRN Electronic Journal.

Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders

S. Holland, P. Hanley, C. Cruz, 2019, Front. Immunol..

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

P. Hanley, J. Blaney, C. Cruz, 2017, Molecular therapy. Methods & clinical development.

Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin Lymphoma.

L. Gordon, C. Bollard, A. Lin, 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

P. Hanley, C. Cruz, C. Rooney, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

D. Nixon, P. Hanley, C. Bollard, 2019, Molecular therapy. Methods & clinical development.

T-cell therapies for HIV: Preclinical successes and current clinical strategies.

D. Nixon, C. Bollard, R. B. Jones, 2016, Cytotherapy.

Abstract CT031: GD2 CAR T cells mediate clinical activity and manageable toxicity in children and young adults with DIPG and H3K27M-mutated diffuse midline gliomas

K. Davis, K. Yeom, M. Monje, 2021, Clinical Trials.

Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates

J. Mullins, G. Shaw, C. Bollard, 2023, Frontiers in Immunology.

Long-Term Follow-up of CD19/22 CAR Therapy in Children and Young Adults with B-ALL Reveals Efficacy, Tolerability and High Survival Rates When Coupled with Hematopoietic Stem Cell Transplantation

K. Davis, D. Miklos, B. Sahaf, 2022, Blood.

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Mariella G. Filbin, Shawn M. Gillespie, K. Davis, 2022 .

HLA-haplotype loss after TCRαβ/CD19-depleted haploidentical HSCT

A. Bertaina, Shabnum Patel, B. M. Zhang, 2020, Bone Marrow Transplantation.

Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells

M. Pellegrini, T. Daniels, G. Helguera, 2011, Leukemia & lymphoma.

Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing

C. Mackall, E. Sotillo, H. Balke-Want, 2023, Molecular Cancer.

Inosine Induces Stemness Features in CAR T cells and Enhances Potency

Ansuman T. Satpathy, K. Davis, Louai Labanieh, 2023, bioRxiv.

CD22-CAR T-Cell Therapy Mediates High Durable Remission Rates in Adults with Large B-Cell Lymphoma Who Have Relapsed after CD19-CAR T-Cell Therapy

K. Davis, Y. Natkunam, D. Miklos, 2021, Blood.

Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells

M. Pellegrini, G. Helguera, M. Penichet, 2011, Leukemia & lymphoma.

Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation.

C. Cruz, S. Lam, C. Bollard, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.